• Health & Medicine

£5m stratified medicine programme launched to personalise care for bowel cancer patients

Cancer Research UK and the Medical Research Council jointly launched a Stratified Medicine Consortium to help personalise bowel cancer treatment Cancer Research UK and the Medical Research Council jointly launched a Stratified Medicine Consortium to help personalise bowel cancer treatment

14 April 2015

• Health & Medicine
• Science & Technology

Pancreatic cancer has four distinct types

Researchers have found that pancreatic cancer can be split into four unique types, a discovery that could help improve treatments for the disease. Researchers have found that pancreatic cancer can be split into four unique types, a discovery that could help improve treatments for the disease.

25 February 2015

• Health & Medicine

Revolutionary clinical trial aims to advance lung cancer treatment thanks to Cancer Research UK and Pharma partnership

Cancer Research UK is partnering with pharmaceutical companies to create a pioneering clinical trial for patients with advanced lung cancer  Cancer Research UK is partnering with pharmaceutical companies to create a pioneering clinical trial for patients with advanced lung cancer 

17 April 2014

• Health & Medicine

New research shows ‘DNA tags’ could guide treatment for advanced ovarian cancer

A Cancer Research UK study has identified chemical 'tags' on DNA in patients’ tumours that could help doctors decide the type of chemotherapy women with advanced ovarian cancer should receive, according to a new paper published in the journal Clinical Cancer Research. A Cancer Research UK study has identified chemical 'tags' on DNA in patients’ tumours that could help doctors decide the type of chemotherapy women with advanced ovarian cancer should receive, according to a new paper published in the journal Clinical Cancer Research.

15 October 2013

• Health & Medicine

Emma Griffin appointed new Chair of the board for Cancer Research UK’s Catalyst Club

Cancer Research UK announced today that Emma Griffin will be assuming the role of Chair of the Board for Cancer Research UK's Catalyst Club with immediate effect. Cancer Research UK announced today that Emma Griffin will be assuming the role of Chair of the Board for Cancer Research UK's Catalyst Club with immediate effect.

25 September 2013

• Health & Medicine

Scientists develop simple blood test to track tumour evolution in cancer patients

Scientists have developed a new way of looking at how tumours evolve in real-time and develop drug resistance by tracking changes in blood. Scientists have developed a new way of looking at how tumours evolve in real-time and develop drug resistance by tracking changes in blood.

7 April 2013

• Health & Medicine

Blood test reveals women's response to breast cancer treatment

Breast tumour DNA circulating in the bloodstream could be used to measure how well a woman's cancer is responding to treatment, according to a new Cancer Research UK study published in the New England Journal of Medicine. Breast tumour DNA circulating in the bloodstream could be used to measure how well a woman's cancer is responding to treatment, according to a new Cancer Research UK study published in the New England Journal of Medicine.

13 March 2013

• Health & Medicine

Skin rash predicts survival benefit from latest lung cancer drug

Elderly patients with advanced non small cell lung cancer (NSCLC) who developed a rash within 28 days of receiving the targeted drug erlotinib (Tarceva) survived on average 6.2 months, compared to 4.1 months for patients who were given a placebo, results from a major phase III Cancer Research UK-funded trial show today (Tuesday). Elderly patients with advanced non small cell lung cancer (NSCLC) who developed a rash within 28 days of receiving the targeted drug erlotinib (Tarceva) survived on average 6.2 months, compared to 4.1 months for patients who were given a placebo, results from a major phase III Cancer Research UK-funded trial show today (Tuesday).

16 October 2012

• Health & Medicine

Cancer Research UK initiative attracts innovative targeted cancer trials to the UK

A Cancer Research UK initiative to improve cancer gene testing has prompted two pharmaceutical companies to plan pioneering international trials into targeted cancer treatments in the UK. A Cancer Research UK initiative to improve cancer gene testing has prompted two pharmaceutical companies to plan pioneering international trials into targeted cancer treatments in the UK.

31 May 2012

• Science & Technology
• Health & Medicine

Cancer genes differ in different parts of a tumour

Taking a sample from just one part of a tumour may not give a full picture of its 'genetic landscape', according to a landmark study published in the New England Journal of Medicine today (Wednesday). Taking a sample from just one part of a tumour may not give a full picture of its 'genetic landscape', according to a landmark study published in the New England Journal of Medicine today (Wednesday).

7 March 2012

• Health & Medicine

Hundreds more breast cancer patients should be tested for BRCA1 gene

Leading breast cancer experts are calling for women under 50 diagnosed with triple-negative breast cancer to be offered testing for faults in the BRCA1 gene. Leading breast cancer experts are calling for women under 50 diagnosed with triple-negative breast cancer to be offered testing for faults in the BRCA1 gene.

15 February 2012

• Health & Medicine

Women with faulty BRCA genes more likely to survive ovarian cancer

Ovarian cancer patients who carry BRCA1 or BRCA2 mutations are significantly more likely to survive the disease than women without these faulty genes, according to research published in the Journal of the American Medical Association. Ovarian cancer patients who carry BRCA1 or BRCA2 mutations are significantly more likely to survive the disease than women without these faulty genes, according to research published in the Journal of the American Medical Association.

24 January 2012